文献速递肝病消化道肿瘤与早癌

在肝细胞癌中下调的钙调磷酸酶调节因子1基因亚型4通过抑制NFAT1核转位阻止癌细胞增殖、迁移、侵袭及原位肿瘤转移

Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
PubMed 文献 · Gastroenterology · 2017-06-02

研究比较14对原发肝细胞癌与癌旁肝组织中21号染色体基因表达,发现RCAN1.4在癌组织中显著下调,且低表达与晚期肿瘤分期、低分化、较大肿瘤及血管侵犯相关,低表达者总生存时间和复发时间更短;体外过表达RCAN1.4可抑制癌细胞增殖、迁移和侵袭,其通过抑制钙调磷酸酶活性及NFAT1核转位减少IGF1和VEGFA表达。

要点

  • RCAN1.4 mRNA和蛋白在原发性肝细胞癌中较癌旁肝组织显著降低。
  • RCAN1.4低表达与晚期肿瘤分期、低分化、较大肿瘤及血管侵犯显著相关。
  • RCAN1.4低表达者总生存时间和复发时间较高表达者缩短。

核心结论

  • RCAN1.4在肝细胞癌组织中较非肿瘤肝组织下调。
  • RCAN1.4在体外阻止癌细胞增殖、迁移和侵袭。
  • 过表达RCAN1.4的肝细胞癌细胞通过抑制钙调磷酸酶活性和NFAT1核转位阻止移植瘤生长、血管生成和转移。

研究设计与样本

  • 比较14对原发肝细胞癌与癌旁非癌肝组织使用Affymetrix HG-U133 Plus 2.0芯片的21号染色体基因表达。
  • 收集中国一家医院108例患者的肝细胞癌组织及癌旁正常肝组织进行实时聚合酶链反应和免疫组化分析。
  • 在MHCC97H和HCCLM3细胞中经慢病毒载体过表达RCAN1.4,在SMMC7721和Huh7细胞中用siRNA敲低表达,进行增殖、迁移和侵袭实验。
  • 将过表达或敲低RCAN1.4的肝细胞癌细胞注入裸鼠肝脏或尾静脉,量化肿瘤生长和肺转移数目。
  • 采用亚硫酸氢盐焦磷酸测序和甲基化特异性聚合酶链反应分析CpG岛甲基化,并测定肝细胞癌细胞中钙调磷酸酶磷酸酶活性。

主要发现

  • RCAN1.4 mRNA和蛋白水平在原发性肝细胞癌中较癌旁非癌肝组织显著降低。
  • RCAN1.4 mRNA降低与晚期肿瘤分期、低分化、较大肿瘤尺寸和血管侵犯显著相关。
  • Kaplan-Meier生存分析显示RCAN1.4 mRNA较低的肝细胞癌患者总生存时间和复发时间较短。
  • 在肝细胞癌细胞系中,RCAN1.4表达显著降低增殖、迁移和侵袭活性。
  • 过表达RCAN1.4的肝细胞癌细胞形成较小的移植瘤,转移和血管较少;RCAN1.4通过降低钙调磷酸酶活性并阻断NFAT1核转位抑制IGF1和VEGFA表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Individuals with Down syndrome have a low risk for many solid tumors, prompting the search for tumor suppressor genes on human chromosome 21 (HSA21). We aimed to identify and explore potential mechanisms of tumor suppressors on HSA21 in hepatocellular carcinoma (HCC). METHODS: We compared expression of HSA21 genes in 14 pairs of primary HCC and adjacent noncancer liver tissues using the Affymetrix HG-U133 Plus 2.0 array (Affymetrix, Santa Clara, CA). HCC tissues and adjacent normal liver tissues were collected from 108 patients at a hospital in China for real-time polymerase chain reaction and immunohistochemical analyses; expression levels of regulator of calcineurin 1 (RCAN1) isoform 4 (RCAN1.4) were associated with clinical features. We overexpressed RCAN1.4 from lentiviral vectors in MHCC97H and HCCLM3 cells and knocked expression down using small interfering RNAs in SMMC7721 and Huh7 cells. Cells were analyzed in proliferation, migration, and invasion assays. HCC cells that overexpressed RCAN1.4 or with RCAN1.4 knockdown were injected into livers or tail veins of nude mice; tumor growth and numbers of lung metastases were quantified. We performed bisulfite pyrosequencing and methylation-specific polymerase chain reaction analyses to analyze CpG island methylation. We measured phosphatase activity of calcineurin in HCC cells. RESULTS: RCAN1.4 mRNA and protein levels were significantly decreased in primary HCC compared with adjacent noncancer liver tissues. Reduced levels of RCAN1.4 mRNA were significantly associated with advanced tumor stages, poor differentiation, larger tumor size, and vascular invasion. Kaplan-Meier survival analysis showed that patients with HCCs with lower levels of RCAN1.4 mRNA had shorter time of overall survival and time to recurrence than patients whose tumors had high levels of RCAN1.4 mRNA. In HCC cell lines, expression of RCAN1.4 significantly reduced proliferation, migration, and invasive activity. HCC cells that overexpressed RCAN1.4 formed smaller xenograft tumors, with fewer metastases and blood vessels, than control HCC cells. In HCC cells, RCAN1.4 inhibited expression of insulin-like growth factor 1 and vascular endothelial growth factor A by reducing calcineurin activity and blocking nuclear translocation of nuclear factor of activated T cells (NFAT1). HCC cells incubated with the calcineurin inhibitor cyclosporin A had decreased nuclear level of NFAT1. HCC cells had hypermethylation of a CpG island in the 5' regulatory region of RCAN1.4, which reduced its expression. CONCLUSIONS: RCAN1.4 is down-regulated in HCC tissues, compared with non-tumor liver tissues. RCAN1.4 prevents cell proliferation, migration, and invasion in vitro; overexpressed RCAN1.4 in HCC cells prevents growth, angiogenesis, and metastases of xenograft tumors by inhibiting calcineurin activity and nuclear translocation of NFAT1.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jin H, Wang C, Jin G, et al. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Gastroenterology. 2017. PMID: 28583823. doi:10.1053/j.gastro.2017.05.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。